Union Korea Pharm Co., Ltd. announces an Equity Buyback for 200,000 shares.
May 17, 2021 at 09:34 pm
Share
Union Korea Pharm Co., Ltd. (KOSDAQ:A080720) announces a share repurchase program. Under the program, the company will repurchase up to 200,000 shares. The program is aimed at stock price stability and shareholder value enhancement. The program will expire on August 18, 2021. As of May 17, 2021, the company had no shares in treasury.
UNION KOREA PHARM CO.LTD. is a Korea-based company mainly engaged in the manufacturing and distribution of pharmaceuticals. The Company manufactures and sells specialty medicines through formulations such as solid dosage forms, liquid injections, and cefa powder injections. Major products include antibiotics such as kepodon injection and ceftazime injection 1g for the prevention and treatment of infectious diseases; musculoskeletal drugs for treating arthritis contains unihyal injection and galithio injection; circulatory system dugs for the treatment of cerebrovascular diseases, such as cacetile tab and limasta tab; as well as drugs for digestive system such as digestive disorders. In addition, the Company engaged in the contract manufacturing operation (CMO) business for other pharmaceutical companies. The Company distributes its products within domestic market and to overseas markets including Middle East, Southeast Asia and Latin America.
UNION KOREA PHARM CO., LTD. 
